Literature DB >> 850455

Seventy-six cases of presumed sudden hearing loss occurring in 1973: prognosis and incidence.

F M Byl.   

Abstract

A sudden hearing loss (SHL) research clinic to which 30 members of an ENT Society refer patients, accumulates information about incidence, prognosis, recovery patterns, and treatment of SHL. The diagnostic protocol includes laboratory, audiometric, and radiologic studies; patients are followed for a minimum of 10 months. Among 76 patients seen in 1973, the diagnosis of idiopathic SHL was retained in 52; more specific diagnoses were established in 24. The incidence of SHL in the general population is estimated at 10.7 cases per 100,000. Although the therapeutic protocol was individualized, all patients with idiopathic SHL were advised to restrict dietary sodium, to discontinue use of stimulants, and were given instructions regarding activity. Twenty-six patients received prednisone. Results indicate that prednisone may have a beneficial effect when administered before the 10th day of SHL. Increasing age, hypertension, diabetes, and severe vertigo were found to be poor prognostic indicators. Outcome was significantly better in patients seen early in the course of their illness than in those seen later. Possible etiologic factors include vascular dysfunction and inflammatory response. Further studies of controlled series are needed to establish standards for diagnosis of SHL and its recovery pattern.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 850455     DOI: 10.1002/lary.5540870515

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  19 in total

1.  Current concepts in the diagnosis and treatment of sudden sensorineural hearing loss.

Authors:  J M Schweinfurth; S M Parnes; M Very
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

2.  Positive family history of idiopathic sudden sensorineural hearing loss.

Authors:  A Gäckler; A K Eickelmann; D Brors; S Dazert; J T Epplen; E Kunstmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-07-01       Impact factor: 2.503

3.  Idiopathic sudden sensorineural hearing loss in patients undergoing long-term haemodialysis.

Authors:  Y Makita; S Osato; K Onoyama; M Fujishima; S Fujimi
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

Review 4.  Intratympanic corticosteroids for sudden sensorineural hearing loss.

Authors:  Stefan K Plontke; Christoph Meisner; Sumit Agrawal; Per Cayé-Thomasen; Kevin Galbraith; Anthony A Mikulec; Lorne Parnes; Yaamini Premakumar; Julia Reiber; Anne Gm Schilder; Arne Liebau
Journal:  Cochrane Database Syst Rev       Date:  2022-07-22

5.  Efficacy and safety of systemic, high-dose glucocorticoid therapy for idiopathic sudden sensorineural hearing loss : Study protocol for a three-armed, randomized, triple-blind, multicenter trial (HODOKORT).

Authors:  Stefan K Plontke; Matthias Girndt; Christoph Meisner; Iris Böselt; Beatrice Ludwig-Kraus; Michael Richter; Torsten Rahne
Journal:  HNO       Date:  2022-06-20       Impact factor: 1.330

Review 6.  Perspectives on the pathophysiology and treatment of sudden idiopathic sensorineural hearing loss.

Authors:  Markus Suckfüll
Journal:  Dtsch Arztebl Int       Date:  2009-10-09       Impact factor: 5.594

7.  Steroid treatment in sudden idiopathic neural deafness? Experimental research.

Authors:  H J Boelen
Journal:  Arch Otorhinolaryngol       Date:  1979

8.  [Multicenter trial for sudden hearing loss therapy - planning and concept].

Authors:  S K Plontke; M Girndt; C Meisner; R Probst; I Oerlecke; M Richter; J Steighardt; G Dreier; A Weber; I Baumann; S Plößl; J Löhler; R Laszig; J A Werner; T Rahne
Journal:  HNO       Date:  2016-04       Impact factor: 1.284

9.  [Fibrinogen/LDL apheresis for treatment of sudden hearing loss: an observational study on 152 patients].

Authors:  M Canis; F Heigl; R Hettich; D Osterkorn; K Osterkorn; M Suckfuell
Journal:  HNO       Date:  2008-09       Impact factor: 1.284

10.  The efficacy and safety of systemic injection of Ginkgo biloba extract, EGb761, in idiopathic sudden sensorineural hearing loss: a randomized placebo-controlled clinical trial.

Authors:  Ja-Won Koo; Mun Young Chang; Sung-Cheol Yun; Tae Su Kim; Soo-Keun Kong; Jong Woo Chung; Eui-Kyung Goh
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-11-11       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.